If you have someone that is of normal weight or possibly underweight status, and then you put them on a GLP-1, you can potentially introduce anorexia in that individual, Dr
Reignite Your Wellness Embark on Your Wellness Path Introducing patient specific GLP-1 one wellness therapy program with physician clearance Pioneering Weight Loss Solutions
No weekly dosing is correct
Phase 2 trial data published in the New England Journal of Medicine (2023) demonstrated average reductions in body weight exceeding 20% over 48 weeks in some participants
The medication may indirectly support ketosis by reducing carbohydrate cravings, which makes strict carb restriction easier to maintain
Meanwhile, semaglutide remains on the FDAs shortage list for several dose strengths, though all doses have been reported as available since late October 2024